Shopping with the Grim Reaper in mind

February 22, 2011

Montreal, February 22, 2010 - Fear of death is a universal human emotion, but does it influence our behaviour as consumers? A new study, conducted by a graduate student at Concordia University's John Molson School of Business, has explored how fear of the Grim Reaper translates into Canadian buying patterns. The research has several implications for marketers in these uncertain times.

"It's impossible to watch the news without being bombarded with reports of murders, terrorist attacks, life-threatening epidemics or environmental disasters," says Alex Davidson. He explored the link between consumer behaviour and fear of death in his master's thesis: "The Impact of Mortality Salience Effects on Consumer Behaviour."

"We wanted to learn how existential anxiety affects consumers and what kinds of buying decisions they are likely to make when reminded of their mortality," continues Davidson.

Death or the dentist?

As part of the study, Davidson designed an on-line survey of 540 Canadian men and women aged 18 to 40. Among the findings, increased awareness of death made respondents with lower self esteem more likely to purchase prestige items. Yet for people with high self esteem and older respondents, thoughts of mortality made them less likely to purchase prestige items.

Half the survey group answered a series of open-ended questions to increase their subconscious awareness of death - or in technical terms of their "mortality salience." Participants were asked to describe what emotions the thought of their own death aroused and their expectations about the death process.

The remainder of participants - the control group - was asked to describe their thoughts about going to the dentist and the type of pain it might cause. All participants answered another set of consumer behaviour questions.

Attitudes to charity unaffected

Increases in mortality salience also made younger individuals and those with lower self esteem less inclined to take chances when confronted with what they saw as risky purchase decisions.

"This was the first study of its kind to gather data in this area using online consumer panels," says thesis supervisor Michel Laroche, Concordia's Royal Bank Distinguished Professor in Marketing. "The approach permitted the testing of a hypothesis on a sample that reflects the entire Canadian population."

"Every day people are confronted with purchase decisions," observes Davidson. "Through this study, we've shown that mortality salience plays a greater role than we realized in that decision-making process. This type of research has implications for marketing, but it also offers a better understanding of economic history and the evolution of consumer practices."
-end-
Related links:

Media contact:
Sylvain-Jacques Desjardins
Senior advisor, external communications
Concordia University
Phone: 514-848-2424, ext. 5068
Email: s-j.desjardins@concordia.ca
Twitter: http://twitter.com/concordianews
Concordia news: http://now.concordia.ca

Concordia University

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.